These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26019266)

  • 21. New insights into managing symptoms during statin therapy.
    Robinson JG
    Prog Cardiovasc Dis; 2019; 62(5):390-394. PubMed ID: 31669768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis.
    Wierzbicki AS; Morrell J; Hemsley D; McMahon Z; Crook MA; Wray R
    Curr Med Res Opin; 2010 Sep; 26(9):2141-6. PubMed ID: 20662558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.
    Mancini GB; Tashakkor AY; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng DS; Pearson GJ; Pope J
    Can J Cardiol; 2013 Dec; 29(12):1553-68. PubMed ID: 24267801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In the clinic. Dyslipidemia.
    Kopin LA; Pearson TA
    Ann Intern Med; 2007 Sep; 147(5):ITC9-1-ITC9-16. PubMed ID: 17785482
    [No Abstract]   [Full Text] [Related]  

  • 26. Statin myopathy: the iceberg or its tip?
    Campbell WW
    Muscle Nerve; 2006 Oct; 34(4):387-90. PubMed ID: 16810688
    [No Abstract]   [Full Text] [Related]  

  • 27. The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality.
    Diprose W; Verster F
    Circulation; 2016 Nov; 134(21):1599-1600. PubMed ID: 27881503
    [No Abstract]   [Full Text] [Related]  

  • 28. Statin intolerance - a question of definition.
    Algharably EA; Filler I; Rosenfeld S; Grabowski K; Kreutz R
    Expert Opin Drug Saf; 2017 Jan; 16(1):55-63. PubMed ID: 27645111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Part II. Combination statin plus fibrate regimens (free and fixed)].
    Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():11-9. PubMed ID: 27473466
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risks in the balance: the statins row.
    Hawkes N
    BMJ; 2014 Aug; 349():g5007. PubMed ID: 25103564
    [No Abstract]   [Full Text] [Related]  

  • 32. Universal screening and drug treatment of dyslipidemia in children and adolescents.
    Psaty BM; Rivara FP
    JAMA; 2012 Jan; 307(3):257-8. PubMed ID: 22174386
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
    Burstein B; Altobelli KK; Williams K; Cannon CP; Pencina MJ; Sniderman AD; Thanassoulis G
    Circulation; 2017 Nov; 136(19):1860-1862. PubMed ID: 29109198
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipid-lowering agents and new onset diabetes mellitus.
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2010 Aug; 11(12):1965-70. PubMed ID: 20486831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D: a bright spot in nutrition research. Too little of the sunshine vitamin linked to heart disease, statin-related muscle pain, other conditions.
    Harv Heart Lett; 2009 Dec; 20(4):3. PubMed ID: 20583375
    [No Abstract]   [Full Text] [Related]  

  • 36. Statin efficacy in primary CVD prevention might diminish with patient age.
    Fernández-Ruiz I
    Nat Rev Cardiol; 2019 Apr; 16(4):200. PubMed ID: 30783252
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ezetimibe: rescued by randomization (clinical and mendelian).
    McPherson R; Hegele RA
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):e13-5. PubMed ID: 25550209
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Sensitivity C-Reactive Protein and Statin Initiation.
    Trpkovic A; Stanimirovic J; Rizzo M; Resanovic I; Soskic S; Jevremovic D; Isenovic ER
    Angiology; 2015 Jul; 66(6):503-7. PubMed ID: 25053677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.